nelfinavir has been researched along with Hyperplasia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burns-Naas, LA; Capen, CC; Chen, M; Cook, JC; Evering, W; Furman, G; Gasser, R; Ivett, JL; Jessen, B; McClain, RM; Ryan, TE; Shetty, B; Stevens, G; Theiss, JC; Webber, S; Wu, E; Zorbas, M | 1 |
1 other study(ies) available for nelfinavir and Hyperplasia
| Article | Year |
|---|---|
Increase in thyroid follicular cell tumors in nelfinavir-treated rats observed in a 2-year carcinogenicity study is consistent with a rat-specific mechanism of thyroid neoplasia.
Topics: Adenocarcinoma, Follicular; Administration, Oral; Animals; Aryl Hydrocarbon Hydroxylases; Carcinogenicity Tests; Cell Survival; Cells, Cultured; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Female; Gene Expression; Glucuronosyltransferase; Hepatocytes; HIV Protease Inhibitors; Hyperplasia; Longevity; Male; Nelfinavir; Rats; Rats, Sprague-Dawley; RNA, Messenger; Species Specificity; Thyroid Gland; Thyroid Hormones; Thyroid Neoplasms; Thyroxine | 2005 |